← Evidence map

ArticleFrontiers in pharmacology2023

Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease.

Mohd Adnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37795023